[HTML][HTML] Pancreatic Stellate Cells and the Targeted Therapeutic Strategies in Chronic Pancreatitis

M Chang, W Chen, R Xia, Y Peng, P Niu, H Fan - Molecules, 2023 - mdpi.com
Chronic pancreatitis (CP) is a disease characterized by inflammatory recurrence that
accompanies the development of pancreatic fibrosis. As the mystery of CP pathogenesis is …

[HTML][HTML] Therapeutic strategies to overcome fibrotic barriers to nanomedicine in the pancreatic tumor microenvironment

HY Tanaka, T Nakazawa, A Enomoto, A Masamune… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic cancer is difficult to treat. Novel treatment strategies are
urgently needed to improve the survival rate, which is approximately 10% five years after …

Discoidin domain receptor 1 (DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis

X Li, Q Li, B Xiong, H Chen, X Wang, D Zhang - Pharmacological Research, 2022 - Elsevier
Background and aims Discoidin domain receptor 1 (DDR1) encodes a receptor tyrosine
kinase involved in multiple physiological and pathological processes. DDR1 is expressed in …

[HTML][HTML] Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds

Y Wu, C Zhang, M Guo, W Hu, Y Qiu, M Li… - Frontiers in …, 2022 - frontiersin.org
Chronic pancreatitis (CP) is a precancerous illness linked to pancreatic ductal
adenocarcinoma (PDAC), although the evolutionary mechanism is uncertain. CP is …

[HTML][HTML] Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis

F Kong, Y Pan, D Wu - Biomedicines, 2024 - mdpi.com
In the complex progression of fibrosis in chronic pancreatitis, pancreatic stellate cells (PSCs)
emerge as central figures. These cells, initially in a dormant state characterized by the …

[HTML][HTML] Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease

CM Borza, G Bolas, A Pozzi - Frontiers in Pharmacology, 2022 - frontiersin.org
Following injury the kidney undergoes a repair process, which results in replacement of the
injured tissue with little evidence of damage. However, repetitive injuries or inability of the …

Discoidin domain receptor 1 may be involved in biological barrier homeostasis

X Li, H Chen, D Zhang - Journal of Clinical Pharmacy and …, 2022 - Wiley Online Library
What is known and objective Discoidin domain receptor 1 (DDR1) is a receptor tyrosine
kinase involved in the pathological processes of several diseases, such as keloid formation …

[HTML][HTML] Discoidin Domain Receptor 1 as a potent therapeutic target in solid tumors

S Bibi, W Zeng, P Zheng, SMM Mehmandousti, T Jin - hLife, 2024 - Elsevier
Despite significant discoveries in basic cancer research and improvements in treatment
options and clinical outcomes, cancer remains a major public health concern worldwide …